Updates in chimeric antigen receptor T-cell therapy for lymphoma / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 3-4, 2017.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-507208
Biblioteca responsável:
WPRO
ABSTRACT
Tremendous success has emerged in chimeric antigen receptor (CAR)-T cell therapy over the past few years, especially in leukemia and lymphoma. The first CAR-T cell product might be available in America in 2017 due to the emergence of the critical results. This paper focused on the key data presented at the 58th American Society of Hematology Annual Meeting.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Journal of Leukemia & Lymphoma
Ano de publicação:
2017
Tipo de documento:
Artigo